Does ALEMTUZUMAB Cause Nasopharyngitis? 349 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 349 reports of Nasopharyngitis have been filed in association with ALEMTUZUMAB (Campath). This represents 2.5% of all adverse event reports for ALEMTUZUMAB.
349
Reports of Nasopharyngitis with ALEMTUZUMAB
2.5%
of all ALEMTUZUMAB reports
6
Deaths
139
Hospitalizations
How Dangerous Is Nasopharyngitis From ALEMTUZUMAB?
Of the 349 reports, 6 (1.7%) resulted in death, 139 (39.8%) required hospitalization, and 7 (2.0%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 349 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which ALEMTUZUMAB Alternatives Have Lower Nasopharyngitis Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET